Cord Blood Education for Parents, Health Professionals and Students - Save the Cord Foundation
  • Home
  • Step-by-Step
  • LEARN
    • Cord Blood Facts
    • Types of stem cells
    • Diseases Treated >
      • Regenerative Medicine: Cord Blood is Critical
      • Participate in a Cord Blood Clinical Trial
    • Cord Blood FAQs
    • Cord Blood News >
      • RESEARCH
      • PROJECTS and EVENTS
      • RESOURCES
    • Video Gallery
    • Share the Science Archive
    • Find a Cord Blood Bank
  • Get Involved
    • ABOUT US >
      • Scientific Advisory Board
      • Inspiring Partners
    • Register for Newsletter
    • Our Work in Action >
      • World Cord Blood Day
      • Arizona Public Cord Blood Program
      • Share the Science
      • NEXT GENERATION: Cord Blood
      • Cord Blood Conferences & Workshops
      • World Cancer Day
    • Cord Blood Education Champions
    • Internship Program at University of Arizona
    • Start a Cord Blood Donation Program
    • Contact Us
  • DONATE
  • Spanish Version
    • Step-by-Step Spanish
    • APRENDER >
      • Datos de la sangre del cordón
      • Tipos de celdas
    • ENCUENTRE UN BANCO
    • PARTICIPE >
      • COMENZAR UN PROGRAMA DE DONACION
      • Ensayos Clínicos
    • DONAR
    • VIDEOS EN ESPAÑOL
    • NOTICIAS DE LA SANGRE DEL CORDON >
      • Curar la diabetes con sangre del cordón?
      • Ensayos Clinicos sobre el autismo
      • Controversia respecto a las células madre
      • Medicina regenerativa
  • Search
  • Home
  • Step-by-Step
  • LEARN
    • Cord Blood Facts
    • Types of stem cells
    • Diseases Treated >
      • Regenerative Medicine: Cord Blood is Critical
      • Participate in a Cord Blood Clinical Trial
    • Cord Blood FAQs
    • Cord Blood News >
      • RESEARCH
      • PROJECTS and EVENTS
      • RESOURCES
    • Video Gallery
    • Share the Science Archive
    • Find a Cord Blood Bank
  • Get Involved
    • ABOUT US >
      • Scientific Advisory Board
      • Inspiring Partners
    • Register for Newsletter
    • Our Work in Action >
      • World Cord Blood Day
      • Arizona Public Cord Blood Program
      • Share the Science
      • NEXT GENERATION: Cord Blood
      • Cord Blood Conferences & Workshops
      • World Cancer Day
    • Cord Blood Education Champions
    • Internship Program at University of Arizona
    • Start a Cord Blood Donation Program
    • Contact Us
  • DONATE
  • Spanish Version
    • Step-by-Step Spanish
    • APRENDER >
      • Datos de la sangre del cordón
      • Tipos de celdas
    • ENCUENTRE UN BANCO
    • PARTICIPE >
      • COMENZAR UN PROGRAMA DE DONACION
      • Ensayos Clínicos
    • DONAR
    • VIDEOS EN ESPAÑOL
    • NOTICIAS DE LA SANGRE DEL CORDON >
      • Curar la diabetes con sangre del cordón?
      • Ensayos Clinicos sobre el autismo
      • Controversia respecto a las células madre
      • Medicina regenerativa
  • Search

Share the Science: Dr. Koen Van Besien talks haplo-cord blood transplants for HIV & more

3/23/2023

 
Picture
Save the Cord Foundation and WellSky are proud to welcome Dr. Koen van Besien as our featured speaker for the next edition of Share the Science on Tuesday, March 29th at 2pm US Eastern Time / 11am US Pacific Time. Join us to hear Dr. Koen van Besien from Seidman Cancer Center at University Hospital (Cleveland, Ohio) discuss innovations in cord blood transplants, including haplo-cord transplants for HIV, leukemia and more.

Share the Science is a free webinar series focused on the cord blood industry and the latest research in this field.  As always, we invite both health professionals and the general public to join us for this unique online educational series. Learn more about this exciting educational series here.

The Enduring Promise of Cord Blood:
​HIV, Leukemia & Beyond

For almost 40 years, cord blood transplants have been used in the treatment of more than 80 different life-threatening diseases, most notably leukemia and lymphoma. In recent years, transplant doctors and researchers have pushed cord blood well beyond traditional transplant. In particular, there has been an interest in further refining the cord blood transplant process through various manipulations and combinations so as to better respond to a particular patient's needs and to ultimately expand access and improve outcomes. Dr. van Besien has been a leading figure in this research.

For this exclusive webinar, we have asked Dr. van Besien to tell us about the use of cord blood for his transplant patients and to discuss its advantages/disadvantages when compared to other stem cell sources. In addition, Dr. van Besien will discuss his research regarding the innovation of haplo-cord transplants and how this new process could help expand access and improve outcomes for certain high risk patients. In particular, he will discuss the use of cord blood in the treatment of HIV (namely the New York Patient) and in the mangement of hematological malignancies.

Important topics Dr. van Besien will cover include:
  • The role of donor choice in transplant outcomes.
  • The potential advantages of umbilical cord blood in disease control.
  • The role umbilical cord blood can play in transplants for adults.
  • Important research on HIV (New York Patient) and umbilical cord blood stem cell transplants.
SHARE THE SCIENCE
with

Dr. Koen van Besien
Blood and Marrow Transplant Division Chief,
Seidman Cancer Center at University Hospital in Cleveland, Ohio
 
"The Enduring Promise of Cord Blood" 
Free webinar.  Open to the public.
​
Wednesday, March 29th 2pm US Eastern Time / 11am US Pacific Time
Register Now for Share the Science with Dr. Koen van Besien

About the speaker

Picture
Dr. Koen van Besien
​
Blood and Marrow Transplant Division Chief,
Seidman Cancer Center at University Hospital


With an established reputation for clinical research and care, Dr. van Besien has made numerous contributions to the field of cellular therapy and stem cell transplantation. Most recently, he has focused on methods to extend the use of transplantation to more patients in need. His group has recently reported the first successful transplant for a patient with HIV and leukemia using a haplo-cord graft - a unique procedure developed by his team. The patient remains free of HIV and leukemia more than four years after transplant.

We wish to thank Dr. Koen van Besien for volunteering her time to speak on
Share the Science and sharing his valuable insight
on the use of haplo-cord blood transplants in the treatment of HIV, leukemia and more.
​​
We also wish to also thank our generous sponsor and partner for this event,
WellSky Health, who continue to support cord blood
education through our “Share the Science” series.
Picture
Picture

Share the Science: What is best stem cell source for children with AML? Ask Dr. Heather Stefanski

2/13/2023

 
Picture
Save the Cord Foundation and WellSky are proud to welcome Dr. Heather Stefanski as our featured speakers for the next edition of Share the Science on Tuesday, February 28th at 2pm US Eastern Time / 11am US Pacific Time. Join us to hear Dr. Heather Stefanski discuss how the source of stem cells influences outcomes for pediatric patients with Acute Myeloid Leukemia.

Recording now available in the Share the Science Archive.

Share the Science is a free webinar series focused on the cord blood industry and the latest research in this field.  As always, we invite both health professionals and the general public to join us for this unique online educational series. Learn more about this exciting educational series here.

Treating children with AML:
​What is the best source of stem cells?

Treatment of Acute Myeloid Leukemia (AML) in children often requires a stem cell transplant. Doctors often hope to find a matched sibling for the pediatric patient in need of a hematopoietic stem cell transplant (HSCT). However, when a matched sibling cannot be identified doctors turn to other sources of stem cells from bone marrow and/or cord blood. At this point, doctors will search for matches from possible donors and then begin a delicate decision making process to choose the best stem cell source for their patient. But, what is the "best source" of stem cells? What factors must the transplant team consider?

Relapse and Graft-versus-Host Disease (GvHD) are both potential risks for pediatric patients post transplant. Both can be debilitating or life-threatening to the child.  Transplant teams work daily to balance these risks with the risk of the cancer itself. Multi-center studies provide these medical teams with much needed observations from real world use of various stem cell sources in transplant. Analysis of these observations is critical to the fight against cancer and efforts to find a cure. 

For this reason, we are very pleased to welcome Dr. Heather Stefanski from NMDP BeTheMatch who will discuss in detail a recent multi-center study comparing stem cell sources. Presenting data from "The influence of stem cell source on transplant outcomes for pediatric patients with acute myeloid leukemia" (published by Blood Advances), Dr. Stefanski will review outcomes of more than 300 patients receiving stem cell transplants from cord blood, matched unrelated donors, sibling donors and more. She will discuss the advantages and disadvantages of each and show the overall conclusions of this multi-center study.

Join us on February 28th for this fascinating, in-depth discussion led by a recognized expert in the field of stem cell transplants, Dr. Heather Stefanski. Free and open to all, this webinar is highly recommended for healthcare professionals, transplant teams and those working in cancer research. Likewise, we encourage OBGYNs, nurses, midwives and others who work with expectant parents to watch this webinar so that they can learn how cord blood stem cells are used on a daily basis in the treatment leukemia, particularly in children. 


SHARE THE SCIENCE
with

Dr. Heather Stefanski
Senior Vice President of Medical Services
for Be The Match / National Marrow Donor Program
 
"The Influence of Umbilical Cord Blood on
Treatment for Acute Myeloid Leukemia
" 
Free webinar.  Open to the public.
​
Tuesday, February 28th 2pm US Eastern Time / 11am US Pacific Time

View the recording now in the Share the Science Archive.
​
Watch the Recording Now:  Dr. Heather Stefanski (click HERE)

About the speaker

Picture
Heather Stefanski, MD, PhD
​
​Senior Vice President of Medical Services for Be The Match / National Marrow Donor Program


Heather Stefanski, MD, PhD, understands the unique challenges transplant centers face. Before joining the National Marrow Donor Program® (NMDP)/Be The Match® as the Senior Vice President of Medical Services, she spent 27 years treating patients at the University of Minnesota (U of M) Division of Pediatric Blood and Marrow Transplant and Cellular Therapy.

We wish to thank Dr. Heather Stefanski for volunteering her time to speak on
Share the Science and sharing her valuable insight
on the influence of cord blood stem cells in the treatment of AML in pediatric patients.
​​
We also wish to also thank our generous sponsor and partner for this event,
WellSky Health, who continue to support cord blood
education through our “Share the Science” series.
Picture
Picture

Share the Science: Drs. Malhotra & Zhou - Potential Cord Blood Cell Therapy for Preterm Brain Injury

8/4/2022

 
Picture
​Save the Cord Foundation and WellSky are proud to welcome Dr. Atul Malhotra and Dr. Lindsay Zhou as our featured speakers for the next edition of Share the Science on Wednesday, August 17th, 2022 at 5pm US Eastern Time / 4pm US Central Time. Join us to hear Dr. Malhotra and Dr. Zhou discuss their research on the potential use of cord blood in cell therapy to treat brain injury in preterm infants.

RECORDING NOW AVAILABLE (watch via the Share the Science archive)

​Share the Science is a free webinar series focused on the cord blood industry and the latest research in this field.  As always, we invite both health professionals and the general public to join us for this unique online educational series. Learn more about this exciting educational series here.

Cell Therapy for Brain Injury:
​What does the future hold?

Brain injury continues to be a severe complication as a result of of preterm birth.  In response, prevention and treatment of brain injury in neonates remains a key area of interest for researchers exploring the potential of umbilical cord blood and cord blood-derived cell therapies. In particular, umbilical cord blood-derived cells are being continuously evaluated for their neuroprotective and neuroreparative properties in preclinical and clinical studies. Numerous clinical trials have suggested that cord blood has the potential to reduce apoptosis, inflammatory cytokines and oxidative stress in the brain.

For this edition of Share the Science, we are pleased to welcome both Dr. Atul Malhotra and Dr. Lindsay Zhou from Monash University who will discuss the potential of cord blood in the treatment of brain injury. In particular, they will discuss their own research in this area and a study to test the feasibility of collection and isolation of sufficient UCBCs from cord blood, and the safety of intravenous administration of autologous UCBCs in extremely preterm infants suffering from brain injury during the neonatal period. 

Join us for this fascinating discussion with Dr. Atul Malhotra and Dr. Lindsay Zhou. 
​
SHARE THE SCIENCE
with

Dr. Atul Malhotra & Dr. Lindsay Zhou
Monash Children's Hospital, Department of Paediatrics,
Monash University - Melbourn, Australia

 
"Autologous Umbilical Cord Blood-Derived Cell
Administration in Extreme Preterm Infants" 

Free webinar.  Open to the public.
​
Wednesday, August 17th, 2022  5pm US Eastern Time / 4pm US Central Time
​

RECORDING NOW AVAILABLE
via the Share the Science Archive
Watch NOW via Share the Science Archive:  Cord Blood Cell Therapy for Preterm Brain Injury

About the speakers

Picture
Dr. Atul Malhotra
​
Senior Consultant Neonatologist and Head of the Early Neurodevelopment Clinic at Monash Children's Hospital and Associate Professor (Research) & NHMRC Fellow in the Department of Paediatrics, Monash University.


Associate Professor Atul Malhotra is a Senior Consultant Neonatologist and Head of the Early Neurodevelopment Clinic at Monash Children's Hospital and Associate Professor (Research) & NHMRC Fellow in the Department of Paediatrics, Monash University. He has published over 120 peer-reviewed journal articles, 4 book chapters and his research has attracted over $7.5 million of funding to date. He is also the co-Director of the Newborn Cell Therapies Group at Monash, which has been instrumental in the translation of preclinical therapies from the laboratory to the clinic, including regenerative cell therapies. He led a world-first trial of placental amnion epithelial cells for chronic lung disease of prematurity, and is the Principal Investigator of two cord blood derived cell therapy trials currently recruiting.

Picture
Dr. Lindsay Zhou
​

Consultant Neonatologist at Monash Children's Hospital and a PhD student at the Ritchie Centre and Department of Paediatrics, Monash University.

Dr Lindsay Zhou is a Consultant Neonatologist at Monash Children's Hospital and a PhD student at the Ritchie Centre and Department of Paediatrics, Monash University. Dr. Zhou undertook his paediatric and neonatal training in Melbourne, and also works as a Retrieval Consultant at the Royal Children's Hospital Melbourne. His PhD studies focus on umbilical cord-blood derived cell therapy applications for extremely preterm infants. He is an Associate Investigator on the CordSaFe clinical trial, investigating the safety and feasibility of umbilical cord blood-derived cell collection and administration in infants born at less than 28 weeks.

We wish to thank Dr. Atul Malhotra & Dr. Lindsay Zhou for volunteering their time to speak on
Share the Science and sharing their valuable insight
on the potential of using cord blood in cell therapy to treat preterm brain injury in enfants.
​​
We also wish to also thank our generous sponsor and partner for this event,
WellSky Health, who continue to support cord blood
education through our “Share the Science” series.
Picture
Picture
<<Previous

    Author

    Write something about yourself. No need to be fancy, just an overview.

    Archives

    March 2023
    February 2023
    August 2022
    June 2022
    April 2022
    December 2021
    July 2021
    June 2021
    May 2021
    January 2021
    October 2020
    September 2020
    August 2020
    June 2020
    May 2020
    March 2020
    October 2019
    August 2019
    May 2019
    April 2019
    March 2019
    February 2019
    November 2018
    August 2018
    January 2018
    October 2017
    September 2017
    June 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    October 2016
    September 2016
    August 2016
    June 2016
    March 2016
    January 2016
    December 2015
    November 2015

    Categories

    All
    Projects And Events
    Research
    Share The Science

    RSS Feed

About Save the Cord Foundation

Picture
Save the Cord Foundation, a 501c3 non-profit organization, was established to promote awareness of the life-saving benefits of cord blood based on u​nbiased and factual information. The Foundation educates parents, health professionals and the general public about the need to preserve this valuable medical resource while providing information on both public cord blood donation programs and private family cord blood banks worldwide. Learn more about our global community.

Show your Support

Our mission depends on supporters like you. Please support our cause by making a donation or promoting our website and message where you can. We appreciate all the support!
Picture
Picture
Find us on Spark by Benevity

Join the conversation

Copyright 2022 - All rights reserved. - Privacy Policy - Terms and Conditions
Photos used under Creative Commons from gromin, Mohammed A. Fadil